Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NEOMYCIN Cause Intentional product use issue? 184 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 184 reports of Intentional product use issue have been filed in association with NEOMYCIN (Antibiotic and Pain Relief). This represents 12.2% of all adverse event reports for NEOMYCIN.

184
Reports of Intentional product use issue with NEOMYCIN
12.2%
of all NEOMYCIN reports
170
Deaths
165
Hospitalizations

How Dangerous Is Intentional product use issue From NEOMYCIN?

Of the 184 reports, 170 (92.4%) resulted in death, 165 (89.7%) required hospitalization, and 146 (79.3%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NEOMYCIN. However, 184 reports have been filed with the FAERS database.

What Other Side Effects Does NEOMYCIN Cause?

Drug hypersensitivity (582) Infusion related reaction (560) Drug ineffective (541) Type 2 diabetes mellitus (517) Swelling (491) Pyrexia (484) Rash (484) Systemic lupus erythematosus (483) Rheumatoid arthritis (478) Off label use (471)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which NEOMYCIN Alternatives Have Lower Intentional product use issue Risk?

NEOMYCIN vs NEORAL NEOMYCIN vs NEOSTIGMINE NEOMYCIN vs NEOSTIGMINE METHYLSULFATE NEOMYCIN vs NEPAFENAC NEOMYCIN vs NERATINIB

Related Pages

NEOMYCIN Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue NEOMYCIN Demographics